Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Merck & Co., Inc. $MRK Shares Sold by Advisors Management Group Inc. ADV
Advisors Management Group Inc. ADV reduced its stake in Merck & Co., Inc. by 15.2% during the fourth quarter, selling 10,482 shares and now holding 58,625 shares valued at $6.17 million. This comes as Merck made a strategic acquisition of Terns Pharmaceuticals for $6.7 billion to bolster its pipeline ahead of Keytruda’s patent expiration, a move that has garnered analyst support despite potential challenges like rival bids and a shareholder investigation. Merck also reported strong quarterly earnings, slightly beating estimates, and announced a $0.85 quarterly dividend, while insider selling of 320,176 shares was noted over the past 90 days.